The missing piece in your diabetes management strategy.
Despite Automated Insulin Delivery (AID) systems being the preferred insulin delivery method per the American Diabetes Association3, only ~15% of eligible people with diabetes currently use them.2
SequelConnect is a comprehensive prescription medical benefit program specifically designed to address these barriers and close the gap in diabetes care for your highest-risk members.
SequelConnect addresses this challenge head-on by identifying high-cost members who use insulin and connecting them with insulin therapy technology.
This video has been designed for employers, benefit consultants and partners interested in the SequelConnect program. People living with diabetes and health care providers should visit twiist.com for more information.